These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 4277016)

  • 21. A fluorescence histochemical study of the degeneration and regeneration of noradrenergic nerves in the chick following treatment with 6-hydroxydopamine.
    Bennett T; Malmfors T; Cobb JL
    Z Zellforsch Mikrosk Anat; 1973 Aug; 142(1):103-30. PubMed ID: 4748700
    [No Abstract]   [Full Text] [Related]  

  • 22. The distribution of noradrenaline content in vesicles of different sympathetic nerve terminals.
    Fillenz M
    J Physiol; 1972 Jul; 224(2):64P-65P. PubMed ID: 4672307
    [No Abstract]   [Full Text] [Related]  

  • 23. PERIPHERALLY LOCATED ADRENERGIC NEURONS INNERVATING THE VAS DEFERENS AND THE SEMINAL VESICLE OF THE GUINEA-PIG.
    FALCK B; OWMAN C; SJOSTRAND NO
    Experientia; 1965 Feb; 21():98-100. PubMed ID: 14305502
    [No Abstract]   [Full Text] [Related]  

  • 24. Short- and long-term effects of nerve growth factor on the sympathetic nervous system in the adult mouse.
    Bjerre B; Björklund A; Mobley W; Rosengren E
    Brain Res; 1975 Aug; 94(2):263-77. PubMed ID: 1148872
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Chemical sympathectomy by selective destruction of adrenergic nerve endings with 6-Hydroxydopamine.
    Thoenen H; Tranzer JP
    Naunyn Schmiedebergs Arch Exp Pathol Pharmakol; 1968; 261(3):271-88. PubMed ID: 4387076
    [No Abstract]   [Full Text] [Related]  

  • 26. Chemical lesioning of central monoamine axons by means of 5,6-dihydroxytryptamine and 5,7-dihydroxytryptamine.
    Björklund A; Baumgarten HG; Nobin A
    Adv Biochem Psychopharmacol; 1974; 10():13-33. PubMed ID: 4846535
    [No Abstract]   [Full Text] [Related]  

  • 27. Action of angiotensin on adrenergic nerve endings: enhancement of norepinephrine biosynthesis.
    Roth RH
    Fed Proc; 1972; 31(4):1358-64. PubMed ID: 4338897
    [No Abstract]   [Full Text] [Related]  

  • 28. Differential effects of reserpine and 6-hydroxydopamine on neuropeptide Y (NPY) and noradrenaline in peripheral neurons.
    Lundberg JM; Saria A; Franco-Cereceda A; Hökfelt T; Terenius L; Goldstein M
    Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):331-40. PubMed ID: 2858824
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Absence of degeneration of adrenergic neurons after prolonged treatment with debrisoquin.
    Haeusler G; Lorez HP; Bartholini G; Kettler R; Tranzer JP
    J Pharmacol Exp Ther; 1974 Jun; 189(3):646-58. PubMed ID: 4152315
    [No Abstract]   [Full Text] [Related]  

  • 30. Fixation for electron microscopy and the retention of 3H-noradrenaline by tissues.
    Devine CE; Laverty R
    Experientia; 1968 Nov; 24(11):1156-7. PubMed ID: 4889117
    [No Abstract]   [Full Text] [Related]  

  • 31. The effects of noradrenaline depletion on large dense-cored vesicles in sympathetic nerve terminals.
    Mottram DR
    Neuropharmacology; 1975 Feb; 14(2):91-4. PubMed ID: 1153084
    [No Abstract]   [Full Text] [Related]  

  • 32. Neurochemical properties of adrenergic nerves regenerated after 6-hydroxydopamine.
    Jonsson G; Sachs C
    J Neurochem; 1972 Nov; 19(11):2577-85. PubMed ID: 5086245
    [No Abstract]   [Full Text] [Related]  

  • 33. The effect of 6-hydroxydopa on peripheral adrenergic neurons.
    Kostrzewa R; Jacobowitz D
    J Pharmacol Exp Ther; 1972 Nov; 183(2):284-97. PubMed ID: 5083546
    [No Abstract]   [Full Text] [Related]  

  • 34. Selective destruction of adrenergic nerve terminals by chemical analogues of 6-hydroxydopamine.
    Tranzer JP; Thoenen H
    Experientia; 1973 Mar; 29(3):314-5. PubMed ID: 4708713
    [No Abstract]   [Full Text] [Related]  

  • 35. Prolonged effects of chronic guanethidine treatment on the sympathetic innervation of the genitalia of male rats.
    Gannon BJ; Iwayama T; Burnstock G; Gerkens J; Mashford ML
    Med J Aust; 1971 Jul; 2(4):207-8. PubMed ID: 5093864
    [No Abstract]   [Full Text] [Related]  

  • 36. Absence of degeneration of adrenergic neurones after prolonged treatment of newborn rats with debrisoquin.
    Lorez HP; Kettler R
    Acta Pharmacol Toxicol (Copenh); 1975 Feb; 36(2):132-44. PubMed ID: 237399
    [No Abstract]   [Full Text] [Related]  

  • 37. Octopamine: normal occurrence in sympathetic nerves of rats.
    Molinoff P; Axelrod J
    Science; 1969 Apr; 164(3878):428-9. PubMed ID: 4887742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Electron microscopic identification of adrenergic nerve endings on thyroid epithelial cells.
    Tice LW; Creveling CR
    Endocrinology; 1975 Nov; 97(5):1123-9. PubMed ID: 1183405
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ultrastructural cytochemistry and pharmacology of 5-hydroxytryptamine in adrenergic nerve endings. II. Accumulation of 5-hydroxytryptamine in nerve vesicles containing norepinephrine in rat vas deferens.
    Zieher LM; Jaim-Etcheverry G
    J Pharmacol Exp Ther; 1971 Jul; 178(1):30-41. PubMed ID: 5087403
    [No Abstract]   [Full Text] [Related]  

  • 40. Effects of 6-hydroxydopamine on the uptake and storage of noradrenaline in sympathetic adrenergic neurons.
    Jonsson G; Sachs C
    Eur J Pharmacol; 1970 Feb; 9(2):141-55. PubMed ID: 5437149
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.